Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.
Also called NCT07781462
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT07781462
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07781462. Randomized; double masking; primary purpose treatment. Start 2026-09 (anticipated); primary completion 2027-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intravenous Infusion of Low Dose Ketamine Versus Dexmedetomedine for Delirium Treatment in Acute Heart Failure
- Condition
- Delirium in Intensive Care Unit
- Condition
- Acute Heart Failure (AHF)
- Intervention (Drug)
- Low dose ketamine infusion
- Intervention (Drug)
- Dexmedetomidine infusion
- Lead sponsor
- Alexandria University
Record details
- Record id
cardio:ct-nct07781462- Content hash
136bd7165f20c905474eb8bfe4e8fff1f61d5ee67a0f326dc357279f417a6867